A Prospective Study Comparing the Effect of Rivaroxaban vs. Enoxaparin Given as a Prophylaxis for Deep Venous Thrombosis in Patients Undergoing Bariatric Surgery

Ahmed Heshmat Soliman Ahmed;

Abstract


O
besity is a risk factor for deep vein thrombosis (DVT) and venous thromboembolism (VTE). VTE is the most common cause of mortality in patients undergoing bariatric surgery. Most of the literature is based on European & American patients and specific guidelines for Egyptians do not exist.
Venous thrombosis, comprising deep vein thrombosis (DVT) and pulmonary embolism (PE), occurs with an incidence of approximately 1 per 1000 annually in adult populations. Rates are slightly higher in men than women. Venous thrombosis is a disease of aging, with a rate rising rapidly after age 45 years, and approaching 5–6 per 1000 annually by age 80. There are also differences in incidence of diagnosed venous thrombosis among ethnic groups. An understanding of the risk factors for venous thrombosis is necessary in order to maximize the prevention of this disease in high risk groups of patients. Some of these risk factors are modifiable, while others, like aging and genetic predispositions, are not.


Other data

Title A Prospective Study Comparing the Effect of Rivaroxaban vs. Enoxaparin Given as a Prophylaxis for Deep Venous Thrombosis in Patients Undergoing Bariatric Surgery
Other Titles دراسة مستقبلية للمقارنة بين تأثير عقار الاينوكسابارين و عقار الريفاروكسابان كمضادات التجلط بجرعة وقائية للوقاية من حدوث جلطات الأوردة العميقة بعد إجراء جراحات تقليص الوزن
Authors Ahmed Heshmat Soliman Ahmed
Issue Date 2019

Attached Files

File SizeFormat
CC131.pdf594.2 kBAdobe PDFView/Open
Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

views 8 in Shams Scholar


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.